title: GABA(A) versus GABA(B) in catatonia.
authors: Brendan T
authors: BT
authors: Carroll
authors: Christopher
authors: C
authors: Thomas
authors: Karen C
authors: KC
authors: Tugrul
authors: Cristonel
authors: C
authors: Coconcea
authors: Harold W
authors: HW
authors: Goforth
mesh_terms: D001008:Anxiety Disorders / Q000150:complications / Q000503:physiopathology; D002389:Catatonia / Q000503:physiopathology*; D002637:Chest Pain / Q000150:complications / Q000503:physiopathology; D003693:Delirium / Q000209:etiology / Q000523:psychology; D018757:GABA Modulators / Q000009:adverse effects; D006801:Humans; D008140:Lorazepam / Q000009:adverse effects; D008297:Male; D008875:Middle Aged; D011963:Receptors, GABA-A / Q000502:physiology*; D018080:Receptors, GABA-B / Q000502:physiology*; D013375:Substance Withdrawal Syndrome / Q000503:physiopathology / Q000523:psychology
chemical_list: D018757:GABA Modulators; D011963:Receptors, GABA-A; D018080:Receptors, GABA-B; D008140:Lorazepam